Botulinum toxin prefilled plastic syringe

Patent metadata

Field	Value
Publication number	US-10406290-B2
Application number	US-201515547941-A
Country	US
Kind code	B2
Filing date	Dec 22, 2015
Priority date	Feb 3, 2015
Publication date	Sep 10, 2019
Grant date	Sep 10, 2019

Abstract

The present invention relates to a prefilled plastic container, such as a plastic syringe, comprising an aqueous botulinum toxin formulation. The aqueous botulinum toxin formulation in the prefilled plastic container is stable for a prolonged time period. Furthermore, the present invention relates to a kit comprising the prefilled plastic container, and to the use of the prefilled plastic container for therapeutic and cosmetic purposes.

First claim

The invention claimed is:

1. A prefilled plastic syringe comprising an aqueous botulinum toxin formulation, the plastic syringe comprising
(a) a plastic syringe barrel including a proximal end and a distal end, and a cylindrical wall extending therebetween and defining a barrel lumen, the syringe barrel having a distally projecting tip with a fluid passage extending therethrough and communicating with the barrel lumen, wherein the cylindrical wall has an interior surface optionally coated with a barrier layer,
(b) a capping device having an outlet engaging portion sealingly engaging and closing the distal open outlet end of the syringe, wherein the outlet engaging portion is made of an elastomeric material that optionally has a coating on its surface, and
(c) a plunger rod assembly which extends into the proximal end of the syringe barrel and includes a plunger stopper in sliding fluid-tight engagement with the cylindrical wall of the barrel lumen, wherein the plunger stopper is made of an elastomeric material, which optionally has a coating on at least a portion of the plunger stopper contacting the aqueous botulinum toxin formulation during storage and/or injection,
wherein the elastomeric material of the outlet engaging portion is selected from the group consisting of isoprene rubber, butadiene rubber, butyl rubber, halogenated butyl rubber, and styrene-butadiene rubber, and mixtures thereof, and
the elastomeric material of the plunger stopper is selected from the group consisting of isoprene rubber, butadiene rubber, butyl rubber, halogenated butyl rubber, and styrene-butadiene rubber, and mixtures thereof, and
wherein the toxin activity is not reduced by more than 25%, relative to the initial toxin activity, upon storage of the prefilled plastic syringe for 12 months at 5° C. or 3 months at 25° C.

2. The prefilled plastic syringe of claim 1 , wherein the number of sub-visible particles of equal to or greater than 10 μm is below 1000/ml during storage for 6 to 24 months at 2° C. to 25° C.

3. The prefilled plastic syringe of claim 1 , wherein the pH value is not increased or decreased by more than 10%, relative to the initial pH value, during storage of the prefilled plastic syringe for 6 to 24 months at 2° C. to 25° C., or wherein the pH of the aqueous botulinum toxin formulation during storage is maintained in the range of 6.1 to 7.3, or both.

4. The prefilled plastic syringe of claim 1 , wherein the botulinum toxin is present in the aqueous formulation at a concentration of 10 U/ml to 1000 U/ml.

5. The prefilled plastic syringe of claim 1 , wherein the aqueous botulinum toxin formulation in the prefilled plastic syringe does not contain a buffer.

6. The prefilled plastic syringe of claim 1 , wherein the barrier layer of the syringe barrel is present and is a silicone-free layer or a silicone layer.

7. The prefilled plastic syringe of claim 1 , wherein the optional coating on the outlet engaging portion is present and is a crosslinked silicone coating or a fluoropolymer coating.

8. A kit comprising a prefilled plastic syringe,
wherein said prefilled plastic syringe comprises an aqueous botulinum toxin formulation, the plastic syringe comprising
(a) a plastic syringe barrel including a proximal end and a distal end, and a cylindrical wall extending therebetween and defining a barrel lumen, the syringe barrel having a distally projecting tip with a fluid passage extending therethrough and communicating with the barrel lumen, wherein the cylindrical wall has an interior surface optionally coated with a barrier layer,
(b) a capping device having an outlet engaging portion sealingly engaging and closing the distal open outlet end of the syringe, wherein the outlet engaging portion is made of an elastomeric material that optionally has a coating on its surface, and
(c) a plunger rod assembly which extends into the proximal end of the syringe barrel and includes a plunger stopper in sliding fluid-tight engagement with the cylindrical wall of the barrel lumen, wherein the plunger stopper is made of an elastomeric material, which optionally has a coating on at least a portion of the plunger stopper contacting the aqueous botulinum toxin formulation during storage and/or injection,
wherein the elastomeric material of the outlet engaging portion is selected from the group consisting of isoprene rubber, butadiene rubber, butyl rubber, halogenated butyl rubber, and styrene-butadiene rubber, and mixtures thereof, and
the elastomeric material of the plunger stopper is selected from the group consisting of isoprene rubber, butadiene rubber, butyl rubber, halogenated butyl rubber, and styrene-butadiene rubber, and mixtures thereof, and
wherein the toxin activity is not reduced by more than 25%, relative to the initial toxin activity, upon storage of the prefilled plastic syringe for 12 months at 5° C. or 3 months at 25° C.

9. A method for the treatment of a disease or condition caused by or associated with hyperactive cholinergic innervation of muscles or exocrine glands in a patient, the method comprising locally administering an effective amount of botulinum toxin to a muscle or exocrine gland of the patient by injection using the prefilled plastic syringe according to claim 1 .

10. A method for the cosmetic treatment of the skin, optionally for treating wrinkles of the skin and facial asymmetries, the method comprising locally administering an effective amount of botulinum toxin to a patient by intradermal, subdermal or subcutaneous injection using the prefilled plastic syringe according to claim 1 .

11. The prefilled plastic syringe of claim 1 , wherein the optional coating on the plunger stopper is present and is a crosslinked silicone coating or a fluoropolymer coating.

12. The method of claim 9 , wherein the disease or condition caused by or associated with hyperactive cholinergic innervation of muscles or exocrine glands is selected from the group consisting of dystonia, spasticity, paratonia, diskinesia, focal spasm, strabismus, tremor, tics, migraine, sialorrhea, and hyperhidrosis.

13. The plastic prefilled syringe according to claim 1 , wherein the cylindrical wall has an interior surface coated with a barrier layer.

14. The method according to claim 10 , comprising treating wrinkles of the skin and facial asymmetries.

15. A kit according to claim 8 , further comprising instructions for use of said prefilled plastic syringe.

Assignees

• Merz Pharma Gmbh & Co Kgaa

Inventors

• Vogt Markus

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P25/14

  for treating abnormal movements, e.g. chorea, dyskinesia · CPC title

• A61P25/08

  Antiepileptics; Anticonvulsants · CPC title

• A61P25/06

  Antimigraine agents · CPC title

• A61P25/04

  Centrally acting analgesics, e.g. opioids · CPC title